BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Escobar C, Martí-Almor J, Pérez Cabeza A, Martínez-Zapata MJ. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Real-life Patients With Atrial Fibrillation. A Systematic Review and Meta-analysis. Rev Esp Cardiol (Engl Ed) 2019;72:305-16. [PMID: 29606361 DOI: 10.1016/j.rec.2018.03.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Robson J, Mathur R, Priebe M, Ahmed Z, Ayerbe L. Thromboembolic and haemorrhagic events in patients with atrial fibrillation: a prospective cohort study in UK primary and secondary care. Br J Gen Pract 2019;69:e407-12. [PMID: 31015222 DOI: 10.3399/bjgp19X702269] [Reference Citation Analysis]
2 Savioli G, Ceresa IF, Luzzi S, Gragnaniello C, Giotta Lucifero A, Del Maestro M, Marasco S, Manzoni F, Ciceri L, Gelfi E, Ricevuti G, Bressan MA. Rates of Intracranial Hemorrhage in Mild Head Trauma Patients Presenting to Emergency Department and Their Management: A Comparison of Direct Oral Anticoagulant Drugs with Vitamin K Antagonists. Medicina (Kaunas) 2020;56:E308. [PMID: 32585829 DOI: 10.3390/medicina56060308] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Gilyarevsky SR. Approaches to Assessing the Quality of Observational Studies of Clinical Practice Based on the Big Data Analysis. Racionalʹnaâ farmakoterapiâ v kardiologii 2021;17:584-93. [DOI: 10.20996/1819-6446-2021-08-01] [Reference Citation Analysis]
4 Durand M, Schnitzer ME, Pang M, Carney G, Eltonsy S, Filion KB, Fisher A, Jun M, Kuo IF, Renoux C, Paterson JM, Quail J, Matteau A; Canadian Network for Observational Drug Effect Studies Investigators. Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study. CMAJ Open 2020;8:E877-86. [PMID: 33355273 DOI: 10.9778/cmajo.20200055] [Reference Citation Analysis]
5 Hernández Rojas Z, Dalmau Llorca MR, Aguilar Martín C, Gonçalves AQ, Casajuana M, Fernández-Sáez J, Rodríguez Cumplido D, Forcadell Drago E, Carrasco-Querol N, Pepió Vilaubí JM, Alegret JM. Cost-effectiveness of direct oral anticoagulants versus vitamin K antagonist in atrial fibrillation: A study protocol using Real-World Data from Catalonia (FantasTIC Study). Medicine (Baltimore) 2020;99:e22054. [PMID: 32899067 DOI: 10.1097/MD.0000000000022054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Savioli G, Ceresa IF, Luzzi S, Giotta Lucifero A, Cambiè G, Manzoni F, Preda L, Ricevuti G, Bressan MA. Mild Head Trauma (MHT) and Antiplatelet Therapy. Reply to Lorenzati et al. Comment on "Savioli et al. Mild Head Trauma: Is Antiplatelet Therapy a Risk Factor for Hemorrhagic Complications? Medicina 2021, 57, 357". Medicina (Kaunas) 2021;57:889. [PMID: 34577811 DOI: 10.3390/medicina57090889] [Reference Citation Analysis]
7 Mocek A, Weber V, Schmölders J, Witt H, Gothe H. Preferences for and use of oral anticoagulants for stroke prevention in atrial fibrillation under real-world conditions in Germany: A survey among physicians. Prev Med Rep 2022;28:101861. [PMID: 35757576 DOI: 10.1016/j.pmedr.2022.101861] [Reference Citation Analysis]
8 Xue Z, Zhang H. Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Asians With Atrial Fibrillation: Meta-Analysis of Randomized Trials and Real-World Studies. Stroke 2019;50:2819-28. [PMID: 31422735 DOI: 10.1161/STROKEAHA.119.026054] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 4.3] [Reference Citation Analysis]